The Bundibugyo strain of Ebola has affected several areas of the Democratic Republic of the Congo.
According to the World Health Organization (WHO), hundreds of people have been infected, and many have lost their lives.
The virus is particularly challenging because there is currently no approved vaccine or specific treatment for this strain of Ebola.
Treatment makes the difference
Although there is no targeted medication, proper medical care can still save lives.
Also read: Jeremy Clarkson’s cancer diagnosis puts spotlight on symptom many men ignore
According to the World Health Organization, patients can be helped through fluid therapy, treatment of infections, and close monitoring of bodily functions, Medical Daily reports.
However, not all patients have access to this type of care.
Many of the affected areas in eastern Congo have overstretched healthcare systems with limited resources.
According to WHO, experience from the outbreak shows that improved access to treatment can help increase patients' chances of survival.
Also read: Scientists make surprising discovery: Tropical fruit could help repair gum damage
Advanced treatment
Health authorities in the United States have also monitored a group of people who had been in close contact with an infected patient.
According to the U.S. Centers for Disease Control and Prevention (CDC), none of them developed symptoms after 21 days of monitoring, Medical Daily reports.
American doctor Peter Stafford, who contracted Bundibugyo Ebola while working at a hospital in eastern Congo, has fully recovered.
According to WHO, he was flown to Berlin for treatment and has now been discharged.
Also read: Ozempic changed weight Loss: Experts say the real revolution is still ahead
This demonstrates that patients can survive the disease when they receive prompt and advanced medical care.
Also read: Resistance training can reduce the risk of heart attacks by 44 percent